These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 5257886)
1. Therapeutic equivalency of drugs. Fact or fiction? Stetler CJ Med Ann Dist Columbia; 1969 Jun; 38(6):297-300. PubMed ID: 5257886 [No Abstract] [Full Text] [Related]
2. Pharmaceutical postmarket review: fact or fiction? Schanz SJ Food Drug Law J; 2007; 62(3):493-500. PubMed ID: 17915391 [No Abstract] [Full Text] [Related]
4. Doctors are pivotal to prescription struggle. Chapman S Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688 [No Abstract] [Full Text] [Related]
5. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
6. Drugs of limited commercial value. Van Woert MH N Engl J Med; 1980 Jul; 303(2):114. PubMed ID: 7383068 [No Abstract] [Full Text] [Related]
7. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
8. Generic vs. brand name drugs--defining and enforcing standards. Lasagna LC Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827 [No Abstract] [Full Text] [Related]
9. Generic vs. brand name drugs--quality, not cost, is key issue. Stetler CJ Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133 [No Abstract] [Full Text] [Related]
11. The Food and Drug Administration's requirements for approval of new dental drugs. Gilkes CC Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180 [No Abstract] [Full Text] [Related]
12. Biopharmaceutic equivalency and the role of the Food & Drug Administration. Hodges RM Am J Hosp Pharm; 1968 Mar; 25(3):121-7. PubMed ID: 5658859 [No Abstract] [Full Text] [Related]
13. Veterinary drug availability. Gloyd J J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533 [No Abstract] [Full Text] [Related]
14. Toward more effective drug regulation. Schmidt AM FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532 [No Abstract] [Full Text] [Related]
15. Profitable and nonprofitable drugs. Van Woert MH N Engl J Med; 1978 Apr; 298(16):903-6. PubMed ID: 634333 [No Abstract] [Full Text] [Related]
16. Development of orphan products. FDA Drug Bull; 1983 Apr; 13(1):2-4. PubMed ID: 6852406 [No Abstract] [Full Text] [Related]
17. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
18. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
19. Knowledge is power: legislative control of drug industry trade secrets. O'Reilly JT Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981 [No Abstract] [Full Text] [Related]
20. Who really assures prescription drug quality? J Indiana State Med Assoc; 1979 Mar; 72(3):164. PubMed ID: 422862 [No Abstract] [Full Text] [Related] [Next] [New Search]